These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 14558414)

  • 21. Comparative studies on topical lomefloxacin and ciprofloxacin on ocular kinetic and experimental corneal ulcer.
    Velpandian T; Gupta SK; Gupta YK; Agarwal HC; Biswas NR
    J Ocul Pharmacol Ther; 1999 Dec; 15(6):505-11. PubMed ID: 10609773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Once-daily oral gatifloxacin versus oral levofloxacin in treatment of uncomplicated skin and soft tissue infections: double-blind, multicenter, randomized study.
    Tarshis GA; Miskin BM; Jones TM; Champlin J; Wingert KJ; Breen JD; Brown MJ
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2358-62. PubMed ID: 11451697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral ciprofloxacin, ofloxacin, and lomefloxacin as alternatives to intravenous antimicrobial therapy.
    Belliveau P; Nightingale CH; Quintiliani R; Crowe H; Gousee G
    Conn Med; 1993 Aug; 57(8):539-45. PubMed ID: 8243083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The first 'respiration' fluoroquinolone--levofloxacin (Tavanic) in therapy of bacterial infections. Pharmacodynamics principles in optimization of administration regimens].
    Budanov SV; Vasil'ev AN; Smirnova LB
    Antibiot Khimioter; 2001; 46(7):38-46. PubMed ID: 11697244
    [No Abstract]   [Full Text] [Related]  

  • 25. Levofloxacin in the treatment of urinary tract infections and prostatitis.
    Naber KG
    J Chemother; 2004 Apr; 16 Suppl 2():18-21. PubMed ID: 15255558
    [No Abstract]   [Full Text] [Related]  

  • 26. New generations of quinolones: with particular attention to levofloxacin.
    Ambrose PG; Owens RC; Quintiliani R; Nightingale CH
    Conn Med; 1997 May; 61(5):269-72. PubMed ID: 9197076
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative study on topical and oral administration of ofloxacin for Pseudomonas corneal ulcer in rabbits.
    Shiao S; Isobe Y; Hatano H; Ohno S
    Ophthalmologica; 1995; 209(3):155-9. PubMed ID: 7630623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacteriologic and clinical efficacy of ofloxacin 0.3% versus ciprofloxacin 0.3% ophthalmic solutions in the treatment of patients with culture-positive bacterial keratitis.
    Prajna NV; George C; Selvaraj S; Lu KL; McDonnell PJ; Srinivasan M
    Cornea; 2001 Mar; 20(2):175-8. PubMed ID: 11248824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of gemifloxacin for the treatment of experimental Staphylococcus aureus keratitis.
    Wu X; Jiang H; Xu Y; Yue W; Yang L; Song Z; Chen H; Liu T
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):420-7. PubMed ID: 22360669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic effects of a new quinolone, DU-6859a, on polymicrobial infections in a newly designed model of rat uterine endometritis.
    Mikamo H; Kawazoe K; Sato Y; Izumi K; Tamaya T
    J Antimicrob Chemother; 1998 Jan; 41(1):131-3. PubMed ID: 9511050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The importance of fluoroquinolones in treating pneumonia in the elderly].
    Belousov IuB; Efremenkova OV; Sokolov AV; Tishenkova IF
    Antibiot Khimioter; 1999; 44(12):23-6. PubMed ID: 10687030
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy and safety of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis in pediatric patients.
    Lichtenstein SJ; Rinehart M;
    J AAPOS; 2003 Oct; 7(5):317-24. PubMed ID: 14566313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levofloxacin for drug-resistant Mycobacterium tuberculosis.
    Peloquin CA; Berning SE; Huitt GA; Iseman MD
    Ann Pharmacother; 1998 Feb; 32(2):268-9. PubMed ID: 9496417
    [No Abstract]   [Full Text] [Related]  

  • 34. Community practice patterns for bacterial corneal ulcer evaluation and treatment.
    Park J; Lee KM; Zhou H; Rabin M; Jwo K; Burton WB; Gritz DC
    Eye Contact Lens; 2015 Jan; 41(1):12-8. PubMed ID: 25536529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New fluoroquinolone antibiotics.
    Drug Ther Bull; 1999 Jan; 37(1):6-8. PubMed ID: 10562769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of bacterial ulcers of the cornea in the rabbit: a comparison of administration by eye drops and subconjunctival injections.
    Baum J
    Trans Am Ophthalmol Soc; 1982; 80():369-90. PubMed ID: 6763800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.
    Constantinou M; Daniell M; Snibson GR; Vu HT; Taylor HR
    Ophthalmology; 2007 Sep; 114(9):1622-9. PubMed ID: 17822972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Mucoadhesive Polymeric Formulation on Corneal Permeation of Fluoroquinolones.
    Gade SK; Shivshetty N; Sharma N; Bhatnagar S; Garg P; Venuganti VVK
    J Ocul Pharmacol Ther; 2018 Oct; 34(8):570-578. PubMed ID: 30136888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transfer of ciprofloxacin, ofloxacin and levofloxacin across the perfused human placenta in vitro.
    Polachek H; Holcberg G; Sapir G; Tsadkin-Tamir M; Polachek J; Katz M; Ben-Zvi Z
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):61-5. PubMed ID: 16154040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of intracameral injection of gatifloxacin, levofloxacin on corneal endothelial structure and viability.
    Choi JA; Chung SK
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):425-31. PubMed ID: 19857104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.